000			01971 a2200505 4500
005			20250515120300.0
264		0	_c20080724
008			200807s 0 0 eng d
022			_a1535-3702
024	7		_a10.3181/0712-RM-329 _2doi
040			_aNLM _beng _cNLM
100	1		_aDu, Yunlan
245	0	0	_aMultiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo. _h[electronic resource]
260			_bExperimental biology and medicine (Maywood, N.J.) _cJul 2008
300			_a881-90 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcetylcysteine _xadverse effects
650	0	4	_aAnimals
650	0	4	_aCysteine Proteinase Inhibitors _xadverse effects
650	0	4	_aDisease Models, Animal
650	0	4	_aDopamine _xmetabolism
650	0	4	_aGlial Cell Line-Derived Neurotrophic Factor _xtherapeutic use
650	0	4	_aJNK Mitogen-Activated Protein Kinases _xmetabolism
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMitogen-Activated Protein Kinase Kinases _xmetabolism
650	0	4	_aNerve Degeneration _xmetabolism
650	0	4	_aParkinson Disease _xetiology
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aProteasome Inhibitors
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aRandom Allocation
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSubstantia Nigra _xdrug effects
650	0	4	_ap38 Mitogen-Activated Protein Kinases _xmetabolism
700	1		_aLi, Xuping
700	1		_aYang, Dehua
700	1		_aZhang, Xiaojie
700	1		_aChen, Shen
700	1		_aHuang, Kaixing
700	1		_aLe, Weidong
773	0		_tExperimental biology and medicine (Maywood, N.J.) _gvol. 233 _gno. 7 _gp. 881-90
856	4	0	_uhttps://doi.org/10.3181/0712-RM-329 _zAvailable from publisher's website
999			_c17942227 _d17942227